Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial.

<h4>Background</h4>Suicide is a leading cause of death in adolescents worldwide. Previous research findings suggest that suicidal adolescents with depression have pathophysiological dorsolateral prefrontal cortex (DLPFC) deficits in γ-aminobutyric acid neurotransmission. Interventions wi...

Full description

Bibliographic Details
Main Authors: Deniz Yuruk, Can Ozger, Juan F Garzon, Jarrod M Leffler, Julia Shekunov, Jennifer L Vande Voort, Michael J Zaccariello, Paul A Nakonezny, Paul E Croarkin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0280010
_version_ 1797838609845321728
author Deniz Yuruk
Can Ozger
Juan F Garzon
Jarrod M Leffler
Julia Shekunov
Jennifer L Vande Voort
Michael J Zaccariello
Paul A Nakonezny
Paul E Croarkin
author_facet Deniz Yuruk
Can Ozger
Juan F Garzon
Jarrod M Leffler
Julia Shekunov
Jennifer L Vande Voort
Michael J Zaccariello
Paul A Nakonezny
Paul E Croarkin
author_sort Deniz Yuruk
collection DOAJ
description <h4>Background</h4>Suicide is a leading cause of death in adolescents worldwide. Previous research findings suggest that suicidal adolescents with depression have pathophysiological dorsolateral prefrontal cortex (DLPFC) deficits in γ-aminobutyric acid neurotransmission. Interventions with transcranial magnetic stimulation (TMS) directly address these underlying pathophysiological deficits in the prefrontal cortex. Theta burst stimulation (TBS) is newer dosing approach for TMS. Accelerated TBS (aTBS) involves administering multiple sessions of TMS daily as this dosing may be more efficient, tolerable, and rapid acting than standard TMS.<h4>Materials and methods</h4>This is a randomized, double-blind, sham-controlled trial of sequential bilateral aTBS in adolescents with major depressive disorder (MDD) and suicidal ideation. Three sessions are administered daily for 10 days. During each session, continuous TBS is administered first to the right DPFC, in which 1,800 pulses are delivered continuously over 120 seconds. Then intermittent TBS is applied to the left DPFC, in which 1,800 pulses are delivered in 2-second bursts and repeated every 10 seconds for 570 seconds. The TBS parameters were adopted from prior research, with 3-pulse, 50-Hz bursts given every 200 ms (at 5 Hz) with an intensity of 80% active motor threshold. The comparison group will receive 3 daily sessions of bilateral sham TBS treatment for 10 days. All participants will receive the standard of care for patients with depression and suicidal ideation including daily psychotherapeutic skill sessions. Long-interval intracortical inhibition (LICI) biomarkers will be measured before and after treatment. Exploratory measures will be collected with TMS and electroencephalography for biomarker development.<h4>Discussion</h4>This is the first known randomized controlled trial to examine the efficacy of sequential bilateral aTBS for treating suicidal ideation in adolescents with MDD. Results from this study will also provide opportunities to further understand the neurophysiological and molecular mechanisms of suicidal ideation in adolescents.<h4>Trial registration</h4>Investigational device exemption (IDE) Number: G200220, ClinicalTrials.gov (ID: NCT04701840). Registered August 6, 2020. https://clinicaltrials.gov/ct2/show/NCT04502758?term=NCT04701840&draw=2&rank=1.
first_indexed 2024-04-09T15:44:42Z
format Article
id doaj.art-e42755f397354e8b8f355c5a29af8c0e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-09T15:44:42Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e42755f397354e8b8f355c5a29af8c0e2023-04-27T05:31:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01184e028001010.1371/journal.pone.0280010Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial.Deniz YurukCan OzgerJuan F GarzonJarrod M LefflerJulia ShekunovJennifer L Vande VoortMichael J ZaccarielloPaul A NakoneznyPaul E Croarkin<h4>Background</h4>Suicide is a leading cause of death in adolescents worldwide. Previous research findings suggest that suicidal adolescents with depression have pathophysiological dorsolateral prefrontal cortex (DLPFC) deficits in γ-aminobutyric acid neurotransmission. Interventions with transcranial magnetic stimulation (TMS) directly address these underlying pathophysiological deficits in the prefrontal cortex. Theta burst stimulation (TBS) is newer dosing approach for TMS. Accelerated TBS (aTBS) involves administering multiple sessions of TMS daily as this dosing may be more efficient, tolerable, and rapid acting than standard TMS.<h4>Materials and methods</h4>This is a randomized, double-blind, sham-controlled trial of sequential bilateral aTBS in adolescents with major depressive disorder (MDD) and suicidal ideation. Three sessions are administered daily for 10 days. During each session, continuous TBS is administered first to the right DPFC, in which 1,800 pulses are delivered continuously over 120 seconds. Then intermittent TBS is applied to the left DPFC, in which 1,800 pulses are delivered in 2-second bursts and repeated every 10 seconds for 570 seconds. The TBS parameters were adopted from prior research, with 3-pulse, 50-Hz bursts given every 200 ms (at 5 Hz) with an intensity of 80% active motor threshold. The comparison group will receive 3 daily sessions of bilateral sham TBS treatment for 10 days. All participants will receive the standard of care for patients with depression and suicidal ideation including daily psychotherapeutic skill sessions. Long-interval intracortical inhibition (LICI) biomarkers will be measured before and after treatment. Exploratory measures will be collected with TMS and electroencephalography for biomarker development.<h4>Discussion</h4>This is the first known randomized controlled trial to examine the efficacy of sequential bilateral aTBS for treating suicidal ideation in adolescents with MDD. Results from this study will also provide opportunities to further understand the neurophysiological and molecular mechanisms of suicidal ideation in adolescents.<h4>Trial registration</h4>Investigational device exemption (IDE) Number: G200220, ClinicalTrials.gov (ID: NCT04701840). Registered August 6, 2020. https://clinicaltrials.gov/ct2/show/NCT04502758?term=NCT04701840&draw=2&rank=1.https://doi.org/10.1371/journal.pone.0280010
spellingShingle Deniz Yuruk
Can Ozger
Juan F Garzon
Jarrod M Leffler
Julia Shekunov
Jennifer L Vande Voort
Michael J Zaccariello
Paul A Nakonezny
Paul E Croarkin
Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial.
PLoS ONE
title Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial.
title_full Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial.
title_fullStr Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial.
title_full_unstemmed Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial.
title_short Sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder: Protocol for a randomized controlled trial.
title_sort sequential bilateral accelerated theta burst stimulation in adolescents with suicidal ideation associated with major depressive disorder protocol for a randomized controlled trial
url https://doi.org/10.1371/journal.pone.0280010
work_keys_str_mv AT denizyuruk sequentialbilateralacceleratedthetaburststimulationinadolescentswithsuicidalideationassociatedwithmajordepressivedisorderprotocolforarandomizedcontrolledtrial
AT canozger sequentialbilateralacceleratedthetaburststimulationinadolescentswithsuicidalideationassociatedwithmajordepressivedisorderprotocolforarandomizedcontrolledtrial
AT juanfgarzon sequentialbilateralacceleratedthetaburststimulationinadolescentswithsuicidalideationassociatedwithmajordepressivedisorderprotocolforarandomizedcontrolledtrial
AT jarrodmleffler sequentialbilateralacceleratedthetaburststimulationinadolescentswithsuicidalideationassociatedwithmajordepressivedisorderprotocolforarandomizedcontrolledtrial
AT juliashekunov sequentialbilateralacceleratedthetaburststimulationinadolescentswithsuicidalideationassociatedwithmajordepressivedisorderprotocolforarandomizedcontrolledtrial
AT jenniferlvandevoort sequentialbilateralacceleratedthetaburststimulationinadolescentswithsuicidalideationassociatedwithmajordepressivedisorderprotocolforarandomizedcontrolledtrial
AT michaeljzaccariello sequentialbilateralacceleratedthetaburststimulationinadolescentswithsuicidalideationassociatedwithmajordepressivedisorderprotocolforarandomizedcontrolledtrial
AT paulanakonezny sequentialbilateralacceleratedthetaburststimulationinadolescentswithsuicidalideationassociatedwithmajordepressivedisorderprotocolforarandomizedcontrolledtrial
AT paulecroarkin sequentialbilateralacceleratedthetaburststimulationinadolescentswithsuicidalideationassociatedwithmajordepressivedisorderprotocolforarandomizedcontrolledtrial